Daniel W. Muehl
Chief Financial Officer, Repligen.
Companies
- Clovis OncologyOfficer Apr 1, 2016 to Nov 3, 20221
- RepligenChief financial officer Jan 13, 2006 to Mar 1, 20062
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Clovis Oncology CLVS104,830 shares3Nov 2, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 2, 2022Sold 2,066 shares at $0.98 of Clovis Oncology3
- Nov 2, 2022Sold 2,513 shares at $0.98 of Clovis Oncology3
- Nov 1, 2022Exercised options 4,625 shares of Clovis Oncology3
- Nov 1, 2022Exercised options 5,623 shares of Clovis Oncology3
- Sep 2, 2022Sold 2,234 shares at $1.20 of Clovis Oncology4
- Sep 1, 2022Exercised options 5,063 shares of Clovis Oncology4
- Aug 2, 2022Sold 2,100 shares at $1.46 of Clovis Oncology5
- Aug 2, 2022Sold 2,554 shares at $1.46 of Clovis Oncology5
- Aug 1, 2022Exercised options 4,625 shares of Clovis Oncology5
- Aug 1, 2022Exercised options 5,624 shares of Clovis Oncology5
- Jun 2, 2022Sold 2,327 shares at $0.64 of Clovis Oncology6
- Jun 1, 2022Exercised options 5,062 shares of Clovis Oncology6
- May 2, 2022Sold 2,062 shares at $1.97 of Clovis Oncology7
- May 2, 2022Sold 2,508 shares at $1.97 of Clovis Oncology7
- May 1, 2022Exercised options 4,625 shares of Clovis Oncology7
- May 1, 2022Exercised options 5,623 shares of Clovis Oncology7
- Mar 2, 2022Sold 10,416 shares at $1.87 of Clovis Oncology8
- Mar 2, 2022Sold 290 shares at $1.87 of Clovis Oncology8
- Mar 1, 2022Exercised options 20,250 shares of Clovis Oncology8
- Mar 1, 2022Exercised options 563 shares of Clovis Oncology8
- Feb 2, 2022Sold 2,453 shares at $1.94 of Clovis Oncology9
- Feb 2, 2022Sold 2,983 shares at $1.94 of Clovis Oncology9
- Feb 1, 2022Exercised options 4,625 shares of Clovis Oncology9
- Feb 1, 2022Exercised options 5,625 shares of Clovis Oncology9
- Dec 2, 2021Sold 248 shares at $3.00 of Clovis Oncology10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARClovis Oncology, Officer
- 2SEC EDGARRepligen, Chief financial officer
- 3
- 4SEC EDGARForm 4 filed Sep 6, 2022
- 5SEC EDGARForm 4 filed Aug 3, 2022
- 6SEC EDGARForm 4 filed Jun 3, 2022
- 7SEC EDGARForm 4 filed May 3, 2022
- 8SEC EDGARForm 4 filed Mar 3, 2022
- 9SEC EDGARForm 4 filed Feb 3, 2022
- 10SEC EDGARForm 4 filed Dec 3, 2021